Purpose
To evaluate a low-cost intranasal-administered vaccine to prevent symptomatic respiratory syncytial virus infection in young children in low-and-middle income countries
Grantee
Division
Global Health
Date
OCTOBER 2026
Region served
AMERICA
Committed amount
$4,999,999
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
23
Grantee location
Athens, Georgia, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.